Topic Editors

Department of Pharmacy, University of Salerno, Fisciano, SA, Italy
Department of Pharmaceutical Chemistry and Technology, “Sapienza” University of Rome, 00185 Rome, Italy
Dipartimento di Farmacia/DIFARMA, Università di Salerno, Salerno, Italy

Advances in Analysis Methods for Metabolomics and Lipidomics

Abstract submission deadline
30 November 2026
Manuscript submission deadline
31 January 2027
Viewed by
906

Topic Information

Dear Colleagues,

The increasing need for novel analytical approaches with higher selectivity, speed, and coverage is of the utmost importance in the fields of metabolomics and lipidomics. In terms of prognostics and diagnostics, the ability to quantify and identify different metabolites and lipids in biospecimes, such as biofluids, tissues and lysates, is crucial, while, the use of high-throughput techniques in clinical settings is also highly desirable. This Topic will be focused on the development, validation, and application of original methodologies based on hyphenated methods, such as UHPLC-MS, GC-MS, and CE-MS, aimed at the qualitative–quantitative analysis of metabolites and lipids in complex matrices such as cells, plasma, serum, urine, and tissue homogenates. Particular attention will be given to method optimization and validation as well as the identification and quantitation of the profiled metabolites and lipids.

Dr. Eduardo Sommella
Dr. Giulia Mazzoccanti
Dr. Emanuela Salviati
Topic Editors

Keywords

  • hyphenated chromatography–mass spectrometry method
  • metabolites
  • lipids
  • biological samples
  • electrophoresis mass spectrometry

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Analytica
analytica
3.6 3.7 2020 19 Days CHF 1200 Submit
International Journal of Molecular Sciences
ijms
4.9 9.0 2000 17.8 Days CHF 2900 Submit
Metabolites
metabolites
3.7 6.9 2011 16.7 Days CHF 2700 Submit
Molecules
molecules
4.6 8.6 1996 15.1 Days CHF 2700 Submit
Separations
separations
2.7 4.5 2014 16 Days CHF 2600 Submit
Spectroscopy Journal
spectroscj
- - 2023 23.4 Days CHF 1000 Submit
Chemosensors
chemosensors
3.7 7.3 2013 19.1 Days CHF 2000 Submit

Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

  1. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
  2. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
  3. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
  4. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
  5. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (1 paper)

Order results
Result details
Journals
Select all
Export citation of selected articles as:
14 pages, 960 KB  
Review
A Comprehensive Review on Medium- and Long-Chain Fatty Acid-Derived Metabolites: From Energy Sources to Metabolic Signals
by Jin-Byung Park, Sungyun Cho and Sung-Joon Lee
Metabolites 2026, 16(1), 45; https://doi.org/10.3390/metabo16010045 - 4 Jan 2026
Viewed by 334
Abstract
Medium- and long-chain fatty acids (MLFAs) are increasingly recognized not only as metabolic substrates but also as precursors of diverse bioactive metabolites generated through host and microbial transformations. Recent advances in analytical chemistry and microbiome research have revealed that gut microorganisms catalyze extensive [...] Read more.
Medium- and long-chain fatty acids (MLFAs) are increasingly recognized not only as metabolic substrates but also as precursors of diverse bioactive metabolites generated through host and microbial transformations. Recent advances in analytical chemistry and microbiome research have revealed that gut microorganisms catalyze extensive modifications of dietary MLFAs—producing hydroxylated, conjugated, and keto-fatty acids with enhanced potency toward host receptors. These metabolites exhibit dual activity on classical metabolic receptors, including FFAR1/4 and PPARα/γ, as well as ectopically expressed chemosensory receptors such as olfactory receptors (ORs) and bitter taste receptors (TAS2Rs). This expanded receptor landscape establishes a previously unrecognized chemosensory–metabolic axis that integrates dietary signals, microbial metabolism, and host physiology. Microbial MLFA derivatives such as 10-hydroxyoctadecenoic acid and conjugated linoleic acid regulate incretin secretion, adipogenesis, macrophage polarization, and intestinal barrier function through coordinated activation of FFARs and PPARs. Concurrently, dicarboxylic acids such as azelaic acid activate Olfr544 to modulate lipolysis, ketogenesis, GLP-1 release, and feeding behavior. TAS2Rs also sense oxidized lipids, linking lipid metabolism to immune regulation and enteroendocrine signaling. Collectively, these pathways highlight the microbiome as a metabolic transducer that converts dietary lipids into signaling molecules influencing endocrine, immune, and gut–brain circuits. Understanding the mechanisms governing MLFA bioconversion and receptor engagement provides new opportunities for therapeutic and nutritional intervention. Targeting ORs and TAS2Rs, engineering probiotics to enhance beneficial FA-derived metabolites, and developing receptor-selective synthetic analogs represent promising strategies. Future progress will require integrative approaches combining physiology, biochemistry, metabolomics, and microbial genomics to elucidate receptor specificity and host variability. Full article
Show Figures

Figure 1

Back to TopTop